Our Treatment for Multiple Myeloma at the Mario Lemieux Center for Blood Cancers

Myeloma—also known as multiple myeloma—begins in the bone marrow and affects plasma cells, which are part of the immune system and help your body fight infections. Our experts treat myeloma and related plasma cell disorders using the latest therapies.

Our Treatment Approach

Our center provides patients with access to a team of highly trained myeloma experts. At our Myeloma Specialty Care Center, patients meet with a multidisciplinary team of radiation oncology, medical oncology, and surgical oncology experts to receive a streamlined evaluation and individualized treatment plan during a single visit.

We have more than 30 years of experience in stem cell transplantation and are collaborating on—and sometimes leading—industry-sponsored clinical trials investigating the latest therapies for multiple myeloma. Our customized plans may include stem cell transplantation and immunotherapy, based on your individual needs.

Myeloma Clinical Trials

The Mario Lemieux Center for Blood Cancers offers myeloma clinical trials to provide patients with access to new treatments that may not be available elsewhere.

We are not currently recruiting patients for myeloma clinical trials. Please check back often, as new trials open frequently.